Navigation Links


IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation

Animal Data Shows Prolonged Survival AND Increased PlateletConcentrations SCOTTSDALE, Ariz., March 08, 2007 /PRNewswire-FirstCall/ --ImmuneRegen BioSciences, a wholly-owned subsidiary of IRBioSciences Holdings, Inc. announced today that ongoing analysis ofdata acquired from previously performed animal efficacy studies hasrevealed evidence that ImmuneRegen's developmental stage product,Radi...

Data From Adherex's European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies

RESEARCH TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews via COMTEXNews Network) -- Adherex Technologies Inc. (TSX:AHX)(AMEX:ADH), abiopharmaceutical company with a broad portfolio of oncologyproducts under development, today announced that Dr. AntonellaPerotti, MD, Istituto Nazionale dei Tumori Milano, SENDOFoundation, an investigator in Adherex's European Phase Ib/II studyof single-agent AD...

Arpida adds novel antibiotic AR-2474 to its preclinical pipeline

In vitro microbiology and proof of concept in topical models ofinfection REINACH / BASEL, Switzerland, 8 March 2007 - Arpida Ltd.(SWX: ARPN) today announced positive results of in vitromicrobiological studies with AR-2474 against a large panel ofclinical isolates, including those resistant to various currenttherapies. In addition, topical applications of AR-2474 were foundto be highly ef...

Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404

LONDON and FLORENCE, Italy - 8 March 2007 - Cancer drugdeveloper Antisoma plc (LSE: ASM, US OTC: ATSMY) today announcespositive initial findings from its second, confirmatory phase IItrial of AS1404 in non-small cell lung cancer. This 30-patient trial tested an 1800 mg/m2 dose of AS1404 incombination with carboplatin and paclitaxel chemotherapy.Investigators reported a response rate of 50...

Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder

National Autism Association calls 2006 Pediatrics study fatallyflawed CHICAGO, March 07, 2007 /PRNewswire-USNewswire/ -- New findingspresented yesterday at a National Autism Association meetingbolster claims that vaccines may play a role in the development ofautism spectrum disorders. David Ayoub, MD presented datasuggesting a correlation between mercury- containing vaccines andrates of pe...

Why Is Polio Spreading in Pakistan?

LEWISVILLE, Texas, March 8, 2007--The World Health Organizationhas released new figures that show that polio cases are rising inPakistan. So is this another instance where, as leftist groups constantlyclaim, the pharmaceutical industry is denying important vaccines topoor populations? Um, apparently not. According to London’s Guardiannewspaper, “parents of 24,000 children i...

Scottish Scientists Test ‘Secret Weapon’ Against Tumours

LONDON, March 8, 2007--Cancer Research UK scientists in Glasgowhave devised a new method of attacking cancer cells. They reportthe findings in the Journal of Clinical Investigation* today(Thursday). A team of scientists from the Beatson Institute for CancerResearch gave mice a chemical that caused cancer cells to commitsuicide, significantly slowing the growth of the tumours they werecar...

Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success

Huge clinical development program of first-in-class CB1antagonist rimonabant to show benefits beyond weight reduction andavoid image as life-style drug BARCELONA, Spain | March 08, 2007 | The Business Intelligencefirm La Merie S.L. reported today that Sanofi-Aventis’first-in-class CB1 antagonist Acomplia (rimonabant) has at leastfive competitors in clinical stages up to phase III an...

Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 8, 2007 - Magen BioSciences,Inc., a specialty dermatology company, today announced thepublication of a paper in the March 9, 2007 issue of the journalCell by its co-founder and board member, David E. Fisher, M.D.,Ph.D., that identifies two new functions for an important protein,p53, in the pigmentation of skin. Fisher's study shows that inaddition to i...

Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University

SAN DIEGO--(BUSINESS WIRE)--Mar 8, 2007 - Vaxiion Therapeutics,Inc. today announced that its researchers, in collaboration withSan Diego State University, have discovered a 'minicell' vaccinedelivery system that has potential to protect against severaldisease-causing infections. These findings were published in an advance online edition ofthe journal, Vaccine, and the paper was published to...
[previous] [next]
(Date:2/13/2019)... ... , ... At this year’s Market America | SHOP.COM ... it was announced that the company was now ranked the 36th largest online marketplace ... has optimized its revolutionary “Shopping Annuity” program, making it possible for individuals across the ...
(Date:2/13/2019)... AUSTIN (PRWEB) , ... February ... ... the healthcare innovation community announced ‘ Energizing Health @ SXSW ,’ four ... focused on creating opportunities for community advocates, entrepreneurs, health organizations, industry and ...
(Date:2/13/2019)... & GREENWICH, Conn. (PRWEB) , ... February 13, 2019 , ... ... unless you must clear the white stuff from walkways and driveways. Then, the snow ... just about any joint or muscle you use to remove it,” says noted orthopaedic ...
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and ... Muizz Merchant, an exceptionally talented and knowledgeable dentist from St. Louis, MO, ... dental techniques, such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, ...
(Date:2/13/2019)... MESA, Calif. (PRWEB) , ... February 13, 2019 , ... ... healthcare scholarship. Open to students who choose to pursue a medical-related course of study ... describe their passion for substance abuse disorder and mental health treatment, and how it ...
Breaking Medicine News(10 mins):
... VERSANT HIV-1 RNA Assay (bDNA) delivers unmatched precision ... you're providing physicians with viral load values they ... end and at other critical decision points - ... you need more reasons to choose VERSANT HIV ...
... The genome of the Human Immunodeficiency Virus ... especially in response to anti-viral drug treatment. ... to render the virus resistant to the ... of the treatment.,The detection of mutations in ...
... Diagnostic, Non-Donor Screen. Vironostika HIV assays provide ... additional testing and confirmation. Vironostika HIV-1 ... for the detection of antibody to HIV-1 ... Oral Fluid Vironostika HIV-1 Microelisa System ...
... The OraQuick ADVANCE Rapid ... a single-use, qualitative immunoassay ... Human Immunodeficiency Virus Type ... 2 (HIV-2) in oral ...
Medicine Products:
(Date:2/13/2019)... STUDIO CITY, Calif. (PRWEB) , ... February 13, 2019 , ... ... American (male or female) now has a BMI of 26.5, which is considered overweight ... rapidly from the start of the 1980’s into the new millennium, and now news ...
(Date:2/13/2019)... ... February 13, 2019 , ... WellRyde, a nuVizz Inc transportation solution, announces ... With the initial launch of Trip Market in early August 2018, WellRyde has seen ... span of time, Trip Market has contributed significantly to the annual trip volume of ...
(Date:2/13/2019)... ... February 13, 2019 , ... Co-founded in a parking lot by husband-and-wife team ... empowering place to not only exercise, but to nurture their mental and emotional health ... professional baseball player with the San Francisco Giants and COO Morgan brings marketing expertise ...
Breaking Medicine Technology: